Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Price:
13.61 USD
-20.92%
Market Closed
Updated:
May 9, 2024
Y-mAbs Therapeutics Inc
Other Operating Expenses
|
Y-mAbs Therapeutics Inc
Other Operating Expenses Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
|
Other Operating Expenses
-$50k
|
CAGR 3-Years
72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Operating Expenses
$179m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Operating Expenses
-$791m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Operating Expenses
$51.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Operating Expenses
-$13.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Y-mAbs Therapeutics Inc's Other Operating Expenses?
Other Operating Expenses
-50k
USD
-50k
USD
Based on the financial report for Dec 31, 2023, Y-mAbs Therapeutics Inc's Other Operating Expenses amounts to -50k USD.
What is Y-mAbs Therapeutics Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
72%
72%
Over the last year, the Other Operating Expenses growth was 50%. The average annual Other Operating Expenses growth rates for Y-mAbs Therapeutics Inc have been 72% over the past three years .
You don't have any saved screeners yet
